Our BioScience segment is characterized by service agreements with some of the world’s most respected companies, which may run for one or more years. Our tailor-made innovative solutions offering high added value (Tailor-Made Solutions, TMS), as well as our business in relation to substance libraries (part of the BRAIN BioArchive), exhibit a low correlation with business cycles, and offer the potential for structural growth.
Our BioIndustrial segment focuses primarily on the specialty business, with the production of enzymes, microorganisms and bioactive natural substances. We mainly produce for end markets that are less dependent on cyclical fluctuations, and which are related to nutrition, health and the environment.
Natural products are reporting above-average growth rates, with consumers increasingly focusing on them.